Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Intuitive Surgical (NASDAQ:ISRG) had its price target boosted by Wells Fargo & Company from $600.00 to $654.00 in a research report issued on Friday,MarketScreener reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 20.59% from the stock’s previous close.

A number of other brokerages also recently commented on ISRG. Sanford C. Bernstein reiterated an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Daiwa Capital Markets lifted their price target on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. HSBC boosted their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $608.79.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $542.32 on Friday. The company’s fifty day moving average is $529.62 and its two-hundred day moving average is $505.69. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market capitalization of $194.41 billion, a price-to-earnings ratio of 71.74, a P/E/G ratio of 4.98 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the company earned $1.84 earnings per share. The firm’s revenue was up 22.9% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 109,043 shares of company stock valued at $60,816,225. Insiders own 0.70% of the company’s stock.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in ISRG. Tobam boosted its position in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $27,000. TD Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new stake in Intuitive Surgical during the 1st quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.